| Literature DB >> 12654726 |
Leonardo Salmena1, Benedicte Lemmers, Anne Hakem, Elzbieta Matysiak-Zablocki, Kiichi Murakami, P Y Billie Au, Donna M Berry, Laura Tamblyn, Amro Shehabeldin, Eva Migon, Andrew Wakeham, Denis Bouchard, Wen Chen Yeh, Jane C McGlade, Pamela S Ohashi, Razqallah Hakem.
Abstract
Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans. The in vivo role of caspase 8, a component of this pathway, has eluded analysis in postnatal tissues because of the lack of an appropriate animal model. Targeted disruption of caspase 8 is lethal in utero. We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage. Despite normal thymocyte development in the absence of caspase 8, we observed a marked decrease in the number of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli. caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria. caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency. These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12654726 PMCID: PMC196031 DOI: 10.1101/gad.1063703
Source DB: PubMed Journal: Genes Dev ISSN: 0890-9369 Impact factor: 11.361